Integrated tumor and circulating immune profiling in the NEO-CESQ trial of perioperative cemiplimab for resectable cutaneous squamous cell carcinoma
- DOI
- 10.1136/jitc-2026-016059
- Published
- 2026-11
- Container
- Journal for ImmunoTherapy of Cancer
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/jitc-2026-016059,
title = {Integrated tumor and circulating immune profiling in the NEO-CESQ trial of perioperative cemiplimab for resectable cutaneous squamous cell carcinoma},
author = {Paolo A Ascierto and Paolo Bossi and Mario Mandala and Paola Queirolo and Francesco Spagnolo and Franco Bassetto and Vittorio Rampinelli and Francesco Giovacchini and Paola Schiavo and Elisabetta Pennacchioli and Corrado Caracò and Giampiero Parrinello and Miriam Paone and Claudia Trojaniello and Elisabeth Livingstone and Dirk Schadendorf and Diana Giannarelli and Daniela Massi and Domenico Mallardo and Luisa Piccin},
year = {2026},
journal = {Journal for ImmunoTherapy of Cancer},
doi = {10.1136/jitc-2026-016059},
url = {https://doi.org/10.1136/jitc-2026-016059}
}RIS
TY - JOUR TI - Integrated tumor and circulating immune profiling in the NEO-CESQ trial of perioperative cemiplimab for resectable cutaneous squamous cell carcinoma AU - Paolo A Ascierto AU - Paolo Bossi AU - Mario Mandala AU - Paola Queirolo AU - Francesco Spagnolo AU - Franco Bassetto AU - Vittorio Rampinelli AU - Francesco Giovacchini AU - Paola Schiavo AU - Elisabetta Pennacchioli AU - Corrado Caracò AU - Giampiero Parrinello AU - Miriam Paone AU - Claudia Trojaniello AU - Elisabeth Livingstone AU - Dirk Schadendorf AU - Diana Giannarelli AU - Daniela Massi AU - Domenico Mallardo AU - Luisa Piccin PY - 2026 JO - Journal for ImmunoTherapy of Cancer DO - 10.1136/jitc-2026-016059 UR - https://doi.org/10.1136/jitc-2026-016059 ER -
APA
Ascierto, P. A., Bossi, P., Mandala, M., Queirolo, P., Spagnolo, F., Bassetto, F., Rampinelli, V., Giovacchini, F., Schiavo, P., Pennacchioli, E., Caracò, C., Parrinello, G., Paone, M., Trojaniello, C., Livingstone, E., Schadendorf, D., Giannarelli, D., Massi, D., Mallardo, D., & Piccin, L. (2026). Integrated tumor and circulating immune profiling in the NEO-CESQ trial of perioperative cemiplimab for resectable cutaneous squamous cell carcinoma. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2026-016059
Source records
- crossref · retrieved 2026-11-08T18:21:51.144Z